Sylvie Nathanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sylvie Nathanson has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Georges Deschênes
Service de néphrologie pédiatrique, Hôpital Robert Debré, AP-HP, Paris, France
2 shared publications A. Greder Belan
Service de médecine interne et maladies infectieuses, hôpital André-Mignot, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France
1 shared publication- Alexandre Pupin
Service de Pédiatrie Générale, Centre Hospitalier Sud Francilien, 91100 Corbeil-Essonnes, France
1 shared publication - Alexis Mandelcwajg
Service de Pédiatrie Générale, Centre Hospitalier de Saint-Denis, 93200 Saint-Denis, France
1 shared publication - Arnaud Chalvon
Site de Marne-la-Vallée, Service de Pédiatrie Générale, Grand Hôpital de L’Est Francilien, 77600 Jossigny, France
1 shared publication - Audrey Vizeneux
Service de Pédiatrie Générale, Centre Hospitalier Argenteuil, 95107 Argenteuil, France
1 shared publication
Latest Publications
- Open Access
- 14 July 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2227
Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris
Understanding the clinical presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and prognosis in children is a major issue. Children often present mild symptoms, and some severe forms require paediatric intensive care, with in some cases a fatal prognosis. Our aim was to identify the epidemiological characteristics, clinical presentation, and prognosis of children with coronavirus disease 2019 (Covid-19) hospitalized in Paris suburb hospitals. In this prospective, observational, multicentre study, we included children hospitalized in paediatric departments of Paris suburb hospitals from 23 March 2020 to 10 May 2020, during the national lockdown in France with confirmed SARS-CoV-2 infection (positive RNA test on a nasopharyngeal swab) or highly suspected infection (clinical, biological, and/or radiological data features suggestive for SARS-CoV-2 infection). A total of 192 children were included for confirmed (n = 157) or highly suspected (n = 35) SARS-CoV-2 infection. The median age was one year old (interquartile range 0.125–11) with a sex ratio 1.3:1. Fever was recorded in 147 (76.6%) children and considered poorly tolerated in 29 (15.1%). The symptoms ranged from rhinorrhoea (34.4%) and gastrointestinal (35.5%) to respiratory distress (25%). Only 10 (5.2%) children had anosmia and five (2.6%) had chest pain. An underlying condition was identified in almost 30% of the children in our study. Overall, 24 (12.5%) children were admitted to paediatric intensive care units, 12 required mechanical ventilation, and three died. For children in Paris suburbs, most cases of Covid-19 showed mild or moderate clinical expression. However, one-eighth of children were admitted to paediatric intensive care units and three died.
- 14 July 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (7) , 2227
Open AccessEpidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris
Understanding the clinical presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and prognosis in children is a major issue. Children often present mild symptoms, and some severe forms require paediatric intensive care, with in some cases a fatal prognosis. Our aim was to identify the epidemiological characteristics, clinical presentation, and prognosis of children with coronavirus disease 2019 (Covid-19) hospitalized in Paris suburb hospitals. In this prospective, observational, multicentre study, we included children hospitalized in paediatric departments of Paris suburb hospitals from 23 March 2020 to 10 May 2020, during the national lockdown in France with confirmed SARS-CoV-2 infection (positive RNA test on a nasopharyngeal swab) or highly suspected infection (clinical, biological, and/or radiological data features suggestive for SARS-CoV-2 infection). A total of 192 children were included for confirmed (n = 157) or highly suspected (n = 35) SARS-CoV-2 infection. The median age was one year old (interquartile range 0.125–11) with a sex ratio 1.3:1. Fever was recorded in 147 (76.6%) children and considered poorly tolerated in 29 (15.1%). The symptoms ranged from rhinorrhoea (34.4%) and gastrointestinal (35.5%) to respiratory distress (25%). Only 10 (5.2%) children had anosmia and five (2.6%) had chest pain. An underlying condition was identified in almost 30% of the children in our study. Overall, 24 (12.5%) children were admitted to paediatric intensive care units, 12 required mechanical ventilation, and three died. For children in Paris suburbs, most cases of Covid-19 showed mild or moderate clinical expression. However, one-eighth of children were admitted to paediatric intensive care units and three died.
- 1 January 2018
- Published by Elsevier in Archives de Pédiatrie
- Vol. 25 (1) , 13-17
Apport de la télédermatologie dans un service de pédiatrie hospitalière
- 1 January 2018
- Published by Elsevier in Archives de Pédiatrie
- Vol. 25 (1) , 13-17
Apport de la télédermatologie dans un service de pédiatrie hospitalière
- 1 May 2015
- Published by Elsevier in Archives de Pédiatrie
- Vol. 22 (5) , 159-160
Irruption de la pompe à insuline en pédiatrie générale: les problèmes posés
- 1 May 2015
- Published by Elsevier in Archives de Pédiatrie
- Vol. 22 (5) , 159-160
Irruption de la pompe à insuline en pédiatrie générale: les problèmes posés
- 31 May 2007
- Published by Elsevier in Archives de Pédiatrie
- Vol. 14 (5) , 501-503
Savoir penser à un syndrome hémolytique et urémique (SHU)
- 31 May 2007
- Published by Elsevier in Archives de Pédiatrie
- Vol. 14 (5) , 501-503
Savoir penser à un syndrome hémolytique et urémique (SHU)
- 1 November 2006
- Published by Springer Nature in Pediatric Nephrology
- Vol. 21 (11) , 1769-1771
Secondary failure of plasma therapy in factor H deficiency
We report a patient with homozygous factor H deficiency leading to permanent alternate complement activation and early onset of the hemolytic uremic syndrome. He was successfully treated with weekly infusions of fresh frozen plasma over 4 years, displaying normal blood pressure while only treated with an angiotensin converting enzyme (ACE) inhibitor, a steady level of haptoglobin, low-range proteinuria and normal creatinine clearance. By the end of the fourth year of treatment, he dramatically developed a relapse of hemolytic and uremic syndrome, displaying undetectable haptoglobin, nephrotic range proteinuria and progressive renal failure. Despite a ten-fold increase in the dosage of plasma infusion through daily plasma exchange, haptoglobin remained undetectable while circulating antigenic factor H levels reached 22–24% (normal values 65–140%). Three months following the biological onset of the relapse, a bilateral nephrectomy was performed owing to uncontrolled hypertension and rapidly progressive renal failure. The molecular mechanism of plasma resistance remained unclear while antifactor H antibodies were not detected in the plasma. We suggest that protracted administration of exogenous factor H might not be a long-term strategy in homozygous factor H deficiency.
- 1 November 2006
- Published by Springer Nature in Pediatric Nephrology
- Vol. 21 (11) , 1769-1771
Secondary failure of plasma therapy in factor H deficiency
We report a patient with homozygous factor H deficiency leading to permanent alternate complement activation and early onset of the hemolytic uremic syndrome. He was successfully treated with weekly infusions of fresh frozen plasma over 4 years, displaying normal blood pressure while only treated with an angiotensin converting enzyme (ACE) inhibitor, a steady level of haptoglobin, low-range proteinuria and normal creatinine clearance. By the end of the fourth year of treatment, he dramatically developed a relapse of hemolytic and uremic syndrome, displaying undetectable haptoglobin, nephrotic range proteinuria and progressive renal failure. Despite a ten-fold increase in the dosage of plasma infusion through daily plasma exchange, haptoglobin remained undetectable while circulating antigenic factor H levels reached 22–24% (normal values 65–140%). Three months following the biological onset of the relapse, a bilateral nephrectomy was performed owing to uncontrolled hypertension and rapidly progressive renal failure. The molecular mechanism of plasma resistance remained unclear while antifactor H antibodies were not detected in the plasma. We suggest that protracted administration of exogenous factor H might not be a long-term strategy in homozygous factor H deficiency.
- 1 December 2002
- Published by Springer Nature in Pediatric Nephrology
- Vol. 17 (12) , 1066-1068
Long-term survival of renal graft complicated with Burkitt lymphoma
A 10-year-old boy with steroid-resistant nephrotic syndrome developed disseminated Burkitt lymphoma 2 years after renal transplantation. Treatment consisting of reduction of immunosuppression and polychemotherapy was initiated, and induced complete tumor remission. A severe cerebellar syndrome attributed to high-dose cytarabine occurred during treatment. The patient recovered partially from this complication. Immunosuppression had to be resumed 2 years later because of a chronic rejection. Finally, at last follow-up, the patient was alive with a stable creatinine of 180 micromol/l.
- 1 December 2002
- Published by Springer Nature in Pediatric Nephrology
- Vol. 17 (12) , 1066-1068
Long-term survival of renal graft complicated with Burkitt lymphoma
A 10-year-old boy with steroid-resistant nephrotic syndrome developed disseminated Burkitt lymphoma 2 years after renal transplantation. Treatment consisting of reduction of immunosuppression and polychemotherapy was initiated, and induced complete tumor remission. A severe cerebellar syndrome attributed to high-dose cytarabine occurred during treatment. The patient recovered partially from this complication. Immunosuppression had to be resumed 2 years later because of a chronic rejection. Finally, at last follow-up, the patient was alive with a stable creatinine of 180 micromol/l.